VTRS

NASDAQ

Viatris, Inc. · Healthcare · Pharmaceuticals

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$19.27B

PE Ratio

—

EV to Ebitda

7.7279

Earnings Yield

-19.81%

Revenue (TTM)

$14.29B

Net Income (TTM)

$-3.51B

Revenue (Annual YoY Growth)

-2.83%

Revenue (Quarterly YoY Growth)

6.60%

Profit Margin

-24.59%

Return on Equity

-22.03%

Debt to Equity Ratio

0.9993

Dividend Yield

2.91%

All fundamentals

Core7 fields›

Market Cap$19.27B

Revenue TTM$14.29B

Shares Outstanding1.15B

Float1163647589

Insider Ownership0.45%

Relative Strength90.8

GARP3003

Growth Estimates19 fields›

Revenue Growth (Annual)-2.83%

Revenue Growth (Quarterly YoY)6.60%

Operating Revenue Growth (Annual)0.050442

Operating Revenue Growth (Quarterly YoY)-0.062557

3-Year Revenue Growth-4.04%

5-Year Revenue Growth3.66%

EPS Growth (Annual)-464.89%

EPS Growth (Quarterly YoY)31.80%

3-Year EPS Growth Rate0.00%

5-Year EPS Growth Rate0.00%

LT EPS Growth Estimates3.66%

EBITDA Growth (Annual)-14.93%

EBITDA Growth (Quarterly YoY)16.97%

CFO Growth (Annual)0.56%

CFO Growth (Quarterly YoY)69.01%

FCF Growth (Annual)-4.78%

FCF Growth (Quarterly YoY)71.85%

Dividend Growth (Annual)0.00%

Dividend Growth (Quarterly YoY)0.00%

Operations28 fields›

Revenue TTM$14.29B

Gross Margin TTM38.49%

Gross Margin (Quarterly)40.28%

R&D % of Revenue TTM6.58%

R&D Expenses TTM$941.1M

Operating Margin TTM7.99%

Operating Margin (Quarterly)7.76%

Operating Expenses TTM$4.36B

Profit Margin TTM-24.59%

Profit Margin (Quarterly)-9.18%

Net Income TTM$-3.51B

EPS TTM-2.9603

EPS (Quarterly)-0.2951

EBIT Margin TTM7.99%

EBIT Margin (Quarterly)7.76%

EBITDA Margin TTM27.57%

EBITDA Margin (Quarterly)28.46%

EBITDA TTM$3.94B

CFO % of Revenue TTM16.20%

CFO % of Revenue (Quarterly)22.02%

CFO TTM$2.32B

Cash Margin-0.15%

Capex % of Revenue TTM3.25%

Capital Expenditures$465.1M

FCF % of Revenue TTM12.95%

FCF % of Revenue (Quarterly)15.27%

FCF TTM$1.85B

Fundamental Score5

Efficiency6 fields›

ROE-22.03%

ROA-9.08%

ROIC-11.51%

CROCI6.06%

Stock Comp % (Quarterly)1.33%

Stock Comp % TTM1.24%

Valuation17 fields›

P/E Forward6.1313

P/S Forward1.1752

PEG-0.0111

P/CFO7.5519

P/FCF9.4497

EV/EBITDA (TTM)7.7279

EV/EBITDA Forward7.0461

EV/Revenues (TTM)2.1303

EV/Revenues Forward2.0803

EV/CFO11.9088

EV/FCF (TTM)16.4517

Price To Book1.1693

Price to Tangible Book-0.9064

Earnings Yield-19.81%

FCF Yield10.58%

Dividend Yield2.91%

Value Score5

Relative to Industry5 fields›

Relative Gross Margin (Quarterly)0.7399

Relative P/S0.5408

Relative P/B0.4739

Relative Dividend Yield1.1505

Relative Debt to Equity1.5961

Liquidity15 fields›

Cash Per Share1.2634

Current Ratio1.2998

Cash & ST Assets$1.45B

Total Debt$14.59B

Goodwill & Intangibles$21.86B

Total Assets$37.19B

Total Liabilities$22.48B

Shareholders Equity$14.71B

Debt to Equity0.9993

Debt to Assets39.53%

Interest Expense$478.2M

Times Interest Earned2.3877

CFO to Debt (TTM)0.1587

Debt to EBITDA (TTM)3.704

Goodwill % of Assets58.77%

Yields4 fields›

Dividend Yield2.91%

Earnings Yield-19.81%

Buyback Yield2.89%

Shareholder Yield9.17%

Options Flow8 fields›

Call Volume1177

Put Volume48

Put/Call Ratio0.04078164825828377

Call $ Volume256243

Put $ Volume2652

Put/Call $ Ratio0.010349551012125209

Call OI126061

Put OI42540